Cardiovascular Risk PROCAM Score Calculator

History of diabetes No Yes Smoking No Yes Family history of myocardial infarction No Yes LDL cholesterol mg/dL HDL cholesterol mg/dL Triglycerides mg/dL Systolic blood pressure mmHg PROCAM Score: Explanation and clinical context The PROCAM score is a point based algorithm developed from the Prospective Cardiovascular Munster study. The model estimates the 10 year risk of acute coronary events using age, systolic blood pressure, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglycerides, smoking status, family history of myocardial infarction, and presence of diabetes. The score was derived in a male working population and provides a simple numerical estimate for risk stratification.

The score can support clinical discussion about lifestyle measures and primary prevention treatment options. It is important to recognize the origin of the cohort when interpreting absolute risk estimates for different populations. Contemporary prevention guidelines for Europe support use of updated risk estimation tools that predict combined fatal and non fatal cardiovascular events and recommend local calibration when possible.

Use PROCAM as one component of an integrated assessment that includes clinical judgment, risk enhancers, and, when appropriate, additional testing such as coronary artery calcium scoring. Key practice points Use validated risk calculators that match the patient population. Consider recalibration or alternative models if the population differs from the derivation cohort.

Consider additional testing when uncertainty remains after clinical risk estimation. Estimate absolute risk with the aim of guiding preventive interventions and shared decision making. References Assmann G, Cullen P, Schulte H.

Simple scoring scheme for calculating the risk of acute coronary events based on the 10 year follow up of the prospective cardiovascular Munster PROCAM study. Circulation. 2002;105:310 to 315.

Assmann G. Assessing risk of myocardial infarction and stroke. Clinica Chimica Acta.

2007; reference summary. European Society of Cardiology. 2021 Guidelines for cardiovascular disease prevention in clinical practice.

Use updated tools and consider SCORE2 for European risk estimation. Systematic comparisons and validations show differences in discrimination and calibration across populations and advise cautious interpretation of absolute risk estimates. For comparative analyses and validation studies see review literature.